Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,607 | -4,372 | -26,353 | -19,919 | -13,850 |
| Depreciation Amortization | 422 | 171 | 692 | 530 | 354 |
| Income taxes - deferred | -1,803 | -1,803 | N/A | N/A | 0 |
| Accounts receivable | -147 | 95 | 50,314 | 50,206 | 50,111 |
| Other Working Capital | -9,438 | -6,336 | 18,704 | 21,559 | 22,470 |
| Other Operating Activity | 3,063 | 1,003 | -42,298 | -43,014 | -44,243 |
| Operating Cash Flow | $-17,510 | $-11,242 | $1,059 | $9,362 | $14,842 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -444 | -188 | -413 | -429 | -143 |
| Purchase Of Investment | -12,635 | -7,718 | -53,412 | -40,628 | N/A |
| Sale Of Investment | 47,664 | 23,332 | 7,666 | N/A | 0 |
| Investing Cash Flow | $34,585 | $15,426 | $-46,159 | $-41,057 | $-143 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -29 | -13 | -32 | -23 | -15 |
| Common Stock Issued | 5,869 | 51 | 1,787 | 1,645 | 635 |
| Common Stock Repurchased | -37 | -37 | -17 | -17 | -17 |
| Other Financing Activity | -174 | 0 | -106 | -95 | -57 |
| Financing Cash Flow | $5,629 | $1 | $1,632 | $1,510 | $546 |
| Exchange Rate Effect | -192 | -100 | -873 | -795 | -161 |
| Beginning Cash Position | 11,936 | 11,936 | 56,277 | 56,277 | 56,277 |
| End Cash Position | 34,448 | 16,021 | 11,936 | 25,297 | 71,361 |
| Net Cash Flow | $22,512 | $4,085 | $-44,341 | $-30,980 | $15,084 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,510 | -11,242 | 1,059 | 9,362 | 14,842 |
| Capital Expenditure | -444 | -188 | -413 | -429 | -143 |
| Free Cash Flow | -17,954 | -11,430 | 646 | 8,933 | 14,699 |